Enlightify (NYSE:ENFY) versus ASP Isotopes (NASDAQ:ASPI) Head to Head Review

Enlightify (NYSE:ENFY) and ASP Isotopes (NASDAQ:ASPI) are both small-cap basic materials companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, risk, earnings, analyst recommendations, valuation, dividends and institutional ownership.

Profitability

This table compares Enlightify and ASP Isotopes’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Enlightify	-22.98%	-18.78%	-11.03%
ASP Isotopes	-1,259.12%	-190.44%	-77.22%

Volatility and Risk

Enlightify has a beta of 1.18, meaning that its share price is 18% more volatile than the S&P 500. Comparatively, ASP Isotopes has a beta of 3.55, meaning that its share price is 255% more volatile than the S&P 500.

Analyst Ratings

This is a summary of current recommendations and price targets for Enlightify and ASP Isotopes, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Enlightify	1	0	0	0	1.00
ASP Isotopes	1	0	2	0	2.33

ASP Isotopes has a consensus target price of $13.00, suggesting a potential upside of 122.22%. Given ASP Isotopes’ stronger consensus rating and higher possible upside, analysts clearly believe ASP Isotopes is more favorable than Enlightify.

Insider and Institutional Ownership

0.1% of Enlightify shares are owned by institutional investors. Comparatively, 16.8% of ASP Isotopes shares are owned by institutional investors. 14.2% of Enlightify shares are owned by company insiders. Comparatively, 14.4% of ASP Isotopes shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Earnings & Valuation

This table compares Enlightify and ASP Isotopes”s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Enlightify	$79.21 million	0.00	-$28.41 million	($0.86)	-0.03
ASP Isotopes	$4.14 million	156.62	-$32.33 million	($1.30)	-4.50

Enlightify has higher revenue and earnings than ASP Isotopes. ASP Isotopes is trading at a lower price-to-earnings ratio than Enlightify, indicating that it is currently the more affordable of the two stocks.

About Enlightify

Enlightify, Inc. engages in the research, development, production, and sale of various types of fertilizers and agricultural products. It operates through the following segments: Jinong, Gufeng, and Yuxing. The Jinong segment includes fertilizer products, with focus on humic acid-based compound fertilizer. The Gufeng segment refers to the compound fertilizer, blended fertilizer, organic compound fertilizer, slow-release fertilizers, highly concentrated water-soluble fertilizers, and mixed organic-inorganic compound fertilizer. The Yuxing segment develops and produces agricultural products, such as top-grade fruits, vegetables, flowers, and colored seedlings. The company was founded by Tao Li on February 6, 1987 and is headquartered in Xi’an, China.

About ASP Isotopes

ASP Isotopes Inc., a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235. ASP Isotopes Inc. was incorporated in 2021 and is headquartered in Washington, District Of Columbia.